Literature DB >> 1056314

Enhancement by drugs of metastatic lung nodule formation after intravenous tumour cell injection.

L M van Putten, L K Kram, H H van Dierendonck, T Smink, M Füzy.   

Abstract

In studies on a model of induced pulmonary metastasis in mice a tumour host system was analysed which was not affected by immunogenicity of the tumour for the host; neither intensive immunosuppression nor immunization caused a significant change in the quantity of pulmonary metastatic nodules. In contrast the application of cytostatic drugs and of Corynebacterium parvum could modify the pulmonary resistance to the formation of tumour nodules by a factor greater than 100 in either direction. This finding confirms the observation of others that major modification of the resistance to metastatic tumour formation can occur independently of classical immunological mechanisms. Special attention is drawn to the fact that cyclophosphamide enhances the formation of metastatic nodules in this model by factors of 100 to more than 1,000 whereas other cytostatic drugs including the cyclophosphamide congeners iphosphamide and trophosphamide are active only factors between 2 and 12. The possible practical significance of these findings is discussed.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1056314     DOI: 10.1002/ijc.2910150408

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  40 in total

Review 1.  Radiation enhancement of metastasis: a review.

Authors:  C F von Essen
Journal:  Clin Exp Metastasis       Date:  1991 Mar-Apr       Impact factor: 5.150

2.  A randomized trial of neoadjuvant vs concomitant chemotherapy vs radiotherapy alone in the treatment of stage IV head and neck squamous cell carcinoma.

Authors:  J V Salvajoli; H Morioka; N Trippe; L P Kowalski
Journal:  Eur Arch Otorhinolaryngol       Date:  1992       Impact factor: 2.503

3.  Effects of gamma irradiation on cultured rat and mouse microvessel endothelial cells: metastatic tumor cell adhesion, subendothelial matrix degradation, and secretion of tumor cell growth factors.

Authors:  G L Nicolson; S E Custead; K M Dulski; L Milas
Journal:  Clin Exp Metastasis       Date:  1991 Sep-Oct       Impact factor: 5.150

4.  An assessment of the effects of swainsonine on survival of mice injected with B16-F10 melanoma cells.

Authors:  M J Humphries; K Matsumoto; S L White; R J Molyneux; K Olden
Journal:  Clin Exp Metastasis       Date:  1990 Jan-Feb       Impact factor: 5.150

5.  Non-cytotoxic asialo-GM1-positive cells exert antimetastatic activity.

Authors:  L Strzadala; I Rak; E Ziolo; M Paprocka; C Radzikowski; W Den Otter
Journal:  Cancer Immunol Immunother       Date:  1989       Impact factor: 6.968

Review 6.  The Role of TLR4 in Chemotherapy-Driven Metastasis.

Authors:  Sophia Ran
Journal:  Cancer Res       Date:  2015-05-21       Impact factor: 12.701

7.  Cyclophosphamide enhances human tumor growth in nude rat xenografted tumor models.

Authors:  Yingjen Jeffrey Wu; Leslie L Muldoon; Dana Thomas Dickey; Seth J Lewin; Csanad G Varallyay; Edward A Neuwelt
Journal:  Neoplasia       Date:  2009-02       Impact factor: 5.715

Review 8.  Role of plasma, platelets, and endothelial cells in tumor metastasis.

Authors:  G J Gasic
Journal:  Cancer Metastasis Rev       Date:  1984       Impact factor: 9.264

9.  Investigation of a new murine model of regional lymph node metastasis: characteristics of the model and applications.

Authors:  M Vandendris; P Dumont; P Semal; R Heimann; G Atassi
Journal:  Clin Exp Metastasis       Date:  1985 Jan-Mar       Impact factor: 5.150

Review 10.  Immunology of metastasis. Can the immune response cope with disseminated tumor?

Authors:  P Frost; R S Kerbel
Journal:  Cancer Metastasis Rev       Date:  1983       Impact factor: 9.264

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.